Category Archives: Patent Term Extension

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

TPP is dead, but its legacy lives on

By Arjun Jayadeva, The HinduThe Hindu | February 9, 2017 The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its damaging aspects, like stringent IP provisions, have just migrated to other agreements U.S. President Donald Trump’s … Continue reading

Posted in Data Exclusivity, Evergreening, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

European Commission publishes negotiating proposals for EU-Indonesia trade deal

It is important to note that the EU proposals on IP are TRIPS-plus in multiple regards and would surely reduce policy space in Indonesia and negatively impact access to affordable medicines.  Even a preliminary review of the proposal reveals: A … Continue reading

Posted in IPR Enforcement, Patent Term Extension, TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized | Leave a comment

Refuse trade, investment provisions that threaten access to affordable meds

Positive Malaysian Treatment Access & Advocacy Group (MTAAG+) calls on the Malaysian government to reject trade and investment agreement provisions that threaten access to affordable medicines. MTAAG+ asserts the need to make its position and demand known because of the … Continue reading

Posted in Data Exclusivity, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, TRIPS, TRIPS plus, Uncategorized | Leave a comment

President-Elect Trump Says the TPP is Dead, but What Now for IP?

By Sirena Rubinoff, IPWatchdog |December 15, 2016 President-Elect Donald Trump has announced that he will withdraw the United States from the Trans-Pacific Partnership (TPP) agreement on his first day in office. So ends more than five years of often heated negotiations … Continue reading

Posted in Data Exclusivity, Patent, Patent Term Extension, TPP, Uncategorized | Leave a comment

Regional trade meet should not pave way for monopoly in drugs: Doctors without borders

By Rosamma Thomas, TNN | December 10, 2016 JAIPUR: Negotiators from 16 countries of the Regional Comprehensive Economic Partnership (RCEP) are meeting at Tangerang, Indonesia. Doctors Without Borders/Medecins Sans Frontieres (MSF) and other health groups, days ahead of the meeting, reiterated … Continue reading

Posted in Data Exclusivity, Patent Term Extension, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

RCEP patent clauses lack compassion says Public Health Association

Public Health Association media release 21 October 2016 The Public Health Association of New Zealand (PHA) is calling on New Zealand Government negotiators to oppose clauses in the Regional Comprehensive Economic Partnership (RCEP), currently being negotiated, that would increase the … Continue reading

Posted in Data Exclusivity, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment